Sirio rides Southeast Asia’s nutraceutical boom with major Q4 expansion
CDMO sees remarkable 77% revenue growth across APAC [excluding China] with Australia and SE Asia key markets SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – has reported record revenues in the APAC region, with construction … Read More










